SCHEMBL10153356

SCHEMBL10153356

Fc1ccc2[nH]c(C3CCCN3)nc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN10A Q9Y5Y9 1/20 0.55
PARP1 P09874 7/20 0.44
KCNH2 Q12809 1/20 0.39
CDC7 O00311 6/20 0.38
CCNE1 P24864 3/20 0.38
CDK2 P24941 3/20 0.38
ROCK1 Q13464 3/20 0.38
DBF4 Q9UBU7 3/20 0.38
CCNT1 O60563 1/20 0.38
CDK9 P50750 1/20 0.38
PIM1 P11309 3/20 0.37
CSNK2B P67870 3/20 0.37
CSNK2A1 P68400 3/20 0.37
CIT O14578 1/20 0.37
CYP1A2 P05177 1/20 0.37
CSNK2A2 P19784 1/20 0.37
GSK3B P49841 1/20 0.37
DYRK1A Q13627 1/20 0.37
CSNK2A3 Q8NEV1 1/20 0.37
TAOK3 Q9H2K8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15452944 1.00 SCN10A (0.55) SCN10APARP1KCNH2CDC7CCNE1
SCHEMBL13350394 0.96 SCN10A (0.51) SCN10APARP1KCNH2CDC7CCNE1
SCHEMBL12509313 0.85 SCN10A (0.58) SCN10APARP1CDC7CCNE1CDK2
SCHEMBL9605019 0.84 SCN10A (0.56) SCN10APARP1CDC7CCNE1CDK2
SCHEMBL1645792 0.84 SCN10A (0.56) SCN10APARP1CDC7CCNE1CDK2
SCHEMBL19488467 0.83 SCN10A (0.59) SCN10APARP1CDC7CCNE1CDK2
SCHEMBL12098830 0.83 SCN10A (0.55) SCN10APARP1CDC7CCNE1CDK2
SCHEMBL12332890 0.83 SCN10A (0.55) SCN10APARP1CDC7CCNE1CDK2
SCHEMBL12098828 0.83 SCN10A (0.55) SCN10APARP1CDC7CCNE1CDK2
Hydrochloric Acid SCHEMBL1646698 0.83 SCN10A (0.55) SCN10APARP1CDC7CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107698566-A The microwave synthesis process of the fluorobenzimidazole of 2 pyrroles 5 遵义医学院 2018-02-16 CN disclosed
US-20140275017-A1 CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2014-09-18 US disclosed
US-20140275017-A1 CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2014-09-18 US disclosed
US-8778957-B2 CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2014-07-15 US disclosed
US-8778957-B2 CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2014-07-15 US disclosed
US-20120010193-A1 CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2012-01-12 US disclosed
US-20120010193-A1 CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275017-A1 CGRP RECEPTOR ANTAGONISTS BDKRB1, CALCRL, BDKRB2 SCN10A 576/4885PARP1 2366/4885KCNH2 230/4885
US-20120010193-A1 CGRP RECEPTOR ANTAGONISTS BDKRB1, BDKRB2, CALCRL SCN10A 586/4885PARP1 2384/4885KCNH2 243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.